Hydroxylamine attenuates the effects of simulated subarachnoid hemorrhage in the rat brain and improves neurological outcome

Brain Research

Volumn 850, Issue 1-2, 1999, Pages 225-233

  Ryba, Mirosław S ^a   Gordon Krajcer, Wanda ^a   Walski, Michał ^a   Chalimoniuk, Małgorzata ^a   Chrapusta, Stanisław J ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Amyloid precursor protein; Animal model; Cerebral vasospasm; Neurological deficit; Nitric oxide; Subarachnoid hemorrhage

Indexed keywords

HYDROXYLAMINE;

ANIMAL MODEL; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE; VASOSPASM;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; FEMALE; HIPPOCAMPUS; HYDROXYLAMINE; MALE; MICROSCOPY, ELECTRON; NITRIC OXIDE DONORS; RATS; RATS, WISTAR; SUBARACHNOID HEMORRHAGE;

EID: 0032711338     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02161-7     Document Type: Article

References (70)

1. Afshar J.K.B., Pluta R.M., Boock R.J., Thompson B.G., Oldfield E.H. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J. Neurosurg. 83:1995;118-122.
2. Andrade J., Ramirez R., Conde M., Sobrino F., Bedoya F.J. Nicotinamide inhibits inducible nitric oxide synthase enzyme activity in macrophages by allowing nitric oxide to inhibit its own formation. Life Sci. 61:1997;1843-1850.
3. Aniya Y., Uehara N., Ishii C., Suenaga T., Wada N., Matsuzaki T., Sakanashi M. Evaluation of nitric oxide formation from nitrates in pig coronary arteries. Jpn. J. Pharmacol. 71:1996;101-107.
4. Barkalow F.J., Goodman M.J., Gerritsen M.E., Mayadas T.N. Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion. Blood. 88:1996;4585-4593.
5. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
6. Cespuglio R., Burlet S., Marinesco S., Robert F., Jouvet M. Voltammetric detection of cerebral NO in rats. Variations of the signal throughout the sleep-wakefulness cycle. C. R. Acad. Sci., Ser. III. 319:1996;191-200.
7. Coria F., Moreno A., Torres A., Ahmad I., Ghiso J. Distribution of Alzheimer's disease amyloid precursor in normal human and rat nervous system. Neuropathol. Appl. Neurobiol. 18:1992;27-35.
8. Currie J.R., Ramakrishna N., Burrage T.G., Hwang M.-C., Potempska A., Miller D.L., Mehta P.D., Kim K.S., Wisniewski H.M. Immunolocalization of Alzheimer β-amyloid peptide presursor to cellular membranes in baculovirus expression system. J. Neurosci. Res. 30:1991;687-698.
9. De Garavilla L., Volberg M.L., Pratt P.F., Silver P.J., Buchholz R.A. Lack of cross-tolerance between nitroglycerin and endothelium-derived relaxing factor-mediated vasoactive agents in spontaneously hypertensive rats. Eur. J. Pharmacol. 234:1993;77-82.
10. DeMaster E.G., Rai L., Archer S.L., Weir E.K. Hydroxylamine is a vasorelaxant and a possible intermediate in the oxidative conversion of L-arginine to nitric oxide. Biochem. Biophys. Res. Commun. 163:1989;527-533.
11. Donnelly J.L., Pallotta B.S. Single-channel currents from diethylpyrocarbonate-modified NMDA receptors in cultured rat brain cortical neurons. J. Gen. Physiol. 105:1995;837-859.
12. Dorsch N. Cerebral arterial spasm - a clinical review. Br. J. Neurosurg. 9:1995;403-412.
13. Endo S., Branson P.J., Alksne J.F. Experimental model of symptomatic vasospasm in rabbits. Stroke. 19:1988;1420-1425.
14. Faraci F.M., Heistad D.D. Regulation of large cerebral arteries and cerebral microvascular pressure. Circ. Res. 66:1989;8-17.
15. Friedlich A.L., Butcher L.L. Involvement of free oxygen radicals in beta-amyloidosis: an hypothesis. Neurobiol. Aging. 15:1994;443-455.
16. Germano A.F., Dixon C.E., d'Avella D., Hayes R.L., Tomasello F. Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J. Neurotrauma. 11:1994;345-353.
17. Hino A., Tokuyama Y., Weir B., Takeda J., Yano H., Bell G.I., Macdonald R.L. Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery. 39:1996;562-567.
18. Iadecola C., Zhang F., Casey R., Clark H.B., Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke. 27:1996;1373-1380.
19. Iadecola C., Zhang F., Xu S., Casey R., Ross M.E. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J. Cereb. Blood Flow Metab. 15:1995;378-384.
20. Jackowski A., Crockard A., Burnstock G., Russell R.R., Kristek F. The time course of intracranial pathophysiological changes following experimental subarachnoid hemorrhage in the rat. J. Cereb. Blood Flow Metab. 10:1990;835-849.
21. Juckett M., Zheng Y., Yuan H., Pastor T., Antholine W., Weber M., Vercelotti G. Heme and the endothelium. Effects of nitric oxide on catalytic iron and heme degradation by heme oxygenase. J. Biol. Chem. 273:1998;23388-23397.
22. Kalaria R.N., Bhatti S.U., Palatinsky E.A., Pennington D.H., Shelton E.R., Chan H.W., Perry G., Lust W.D. Accumulation of the β-amyloid precursor protein at sites of ischemic injury in rat brains. NeuroReport. 4:1993;211-214.
23. Kassell N.F. Tirilazad prevents damage after ruptured cerebral aneurysm. Neurosci. Forum. 4:1994;12-13.
24. Kassell N.F., Helm G., Simmons N., Phillips C.D., Cail W.S. Treatment of cerebral vasospasm with intra-arterial papaverine. J. Neurosurg. 77:1992;848-852.
25. Kearney M.F., Brien J.F., Marks G.S., Lei H., Nakatsu K. Thiol agents separate nitric oxide formation from vasodilation induced by glyceryl trinitrate. Drug Metab. Dispos. 26:1998;547-551.
26. Kim K.S., Wen G., Bancher C., Chen C.J., Sapienza V.J., Hong H., Wisniewski H.M. Detection and quantitation of amyloid B-peptide with 2 monoclonal antibodies. Neurosci. Res. Commun. 7:1990;113-122.
27. Kimura M., Dietrich H.H., Dacey R.G. Nitric oxide regulates cerebral arteriolar tone in rats. Stroke. 25:1994;2227-2234.
28. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
29. Lancelot E., Lecanu L., Revaud M.-L., Boulu R.G., Plotkine M., Callebert J. Glutamate induces hydroxyl radical formation in vivo via activation of nitric oxide synthase in Sprague-Dawley rats. Neurosci. Lett. 242:1998;131-134.
30. Mohazzab-H. K.M., Kaminski P.M., Agarwal R., Wolin M.S. Potential role of a membrane-bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside. Circ. Res. 84:1999;220-228.
31. Nakao K., Murata H., Kanamaru K., Waga S. Effects of nitroglycerin on vasospasm and cyclic nucleotides in a primate model of subarachnoid hemorrhage. Stroke. 27:1996;1882-1888.
32. Neil-Dwyer G., Lang D.A., Doshi B., Gerber Ch.-J., Smith P.W.F. Delayed cerebral ischemia: the pathological substrate. Acta Neurochir. 131:1994;137-145.
33. Nilsson O.G., Saveland H., Boris-Moller F., Brandt L., Wieloch T. Increased levels of glutamate in patients with subarachnoid hemorrhage as measured by intracerebral microdialysis. Acta Neurochir. Suppl. 67:1996;45-47.
34. Nishizawa S., Peterson J.W., Shimoyama I., Iwasaki K., Uemura K. Therapeutic effect of a new immunosuppressant, FK-506, on vasospasm after subarachnoid hemorrhage. Neurosurgery. 32:1993;986-992.
35. Ohlstein E.H., Storer B.L. Oxyhemoglobin stimulation of endothelin production in cultured endothelial cells. J. Neurosurg. 77:1992;274-278.
36. Ohta K., Rosner G., Graf R. Nitric oxide generation from sodium nitroprusside and hydroxylamine in brain. NeuroReport. 8:1997;2229-2235.
37. Ozaka T., Doi Y., Kayashima K., Fujimoto S. Weibel-Palade bodies as a storage site of calcitonin gene-related peptide and endothelin-1 in blood vessels of the rat carotid body. Anat. Rec. 247:1997;388-394.
38. Palmer R.M.J., Ferrige A.G., Moncada S S. Nitric oxide release accounts for the biologic activity of endothelium derived relaxing factor. Nature. 327:1987;524-526.
39. Peterson J.W., Nishizawa S., Hackett J.D., Bun T., Teramura A., Zervas N.T. Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke. 21:1990;133-137.
40. Pluta R., Kida E., Lossinsky A.S., Golabek A.A., Mossakowski M.J., Wisniewski H.M. Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest: I. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain. Brain Res. 649:1994;323-328.
41. Pluta R.M., Oldfield E.H., Boock R.J. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J. Neurosurg. 87:1997;746-751.
42. Pluta R.M., Thompson B.G., Dawson T.M., Snyder S.H., Boock R.J., Oldfield E.H. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J. Neurosurg. 84:1996;648-654.
43. Potempska, Styles J., Mehta P., Kim K.S., Miller D.L. Purification and tissue level of the β-amyloid peptide precursor of rat brain. J. Biol. Chem. 266:1991;8464-8469.
44. Reidy M.A., Chopek M., Chao S., McDonald T., Schwartz S.M. Injury induces increase of von Willebrand factor in rat endothelial cells. Am. J. Pathol. 134:1989;857-864.
45. Rickels E., Zumkeller M. Vasospasm after experimentally induced subarachnoid haemorrhage and treatment with nimodipine. Neurochirurgia. 35:1992;99-102.
46. Rossi F., Bianchini E. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225:1996;474-478.
47. Samdani A.F., Dawson T.M., Dawson V.L. Nitric oxide synthase in models of focal ischemia. Stroke. 28:1997;1283-1288.
48. Sano K. Acute ischaemic and delayed ischaemic neurological deficits as the causes of bad grading in aneurysmal subarachnoid haemorrhage. Neurol. Res. 16:1994;35-39.
49. Sasaki T., Ohta T., Kikuchi H., Takakura K., Usui M., Ohnishi H., Kondo A., Tanabe H., Nakamura J., Yamada K.et al. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 35:1994;597-605.
50. Sayama T., Suzuki S., Fukui M. Expression of inducible nitric oxide synthase in rats following subarachnoid hemorrhage. Neurol. Res. 20:1998;79-84.
51. Schagger H., von Jagow G. Tricine-sodium dodecyl sulphate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:1987;368-379.
52. Shivers B.D., Hilbich C., Multhaupt G., Salbaum M., Beyreuther K., Seeburg P.H. Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 7:1988;1365-1370.
53. Smith-Swintosky V.L., Pettigrew L.C., Craddock S.D., Culwell A.R., Rydel R.E., Mattson M.P. Secreted forms of beta-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63:1994;781-784.
54. Southam E., Garthwaite J. Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neurosci. Lett. 130:1991;107-111.
55. Stephenson D.T., Rash K., Clemens J.A. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 593:1992;128-135.
56. Strosznajder J., Chalimoniuk M. Biphasic enhancement of nitric oxide synthase activity and cGMP level following brain ischemia in gerbils. Acta Neurobiol. Exp. 56:1996;71-81.
57. Suo Z., Humphrey J., Kundtz A., Sethi F., Placzek A., Crawford F., Mullan M. Soluble Alzheimers β-amyloid constricts the cerebral vasculature in vivo. Neurosci. Lett. 257:1998;77-80.
58. Thomas T., McLendon C., Sutton E.T., Thomas G. Cerebrovascular endothelial dysfunction mediated by β-amyloid. NeuroReport. 8:1997;1387-1391.
59. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 76:1979;4350-4359.
60. Vickroy T.W., Malphurs W.L. Inhibition of nitric oxide synthase activity in cerebral cortical synaptosomes by nitric oxide donors: evidence for feedback autoregulation. Neurochem. Res. 20:1995;299-304.
61. Wang X., Zhu C., Zhang G., Lu Y. Changes of endothelin during cerebral vasospasm after experimental subarachnoid hemorrhage. Chin. Med. J. 108:1995;586-590.
62. Wakita H., Tomimoto H., Akiguchi I., Ohnishi K., Nakamura S., Kimura J. Regional accumulation of amyloid β/A4 protein precursor in the gerbil brain following transient cerebral ischemia. Neurosci. Lett. 146:1992;135-138.
63. Waldman S.A., Murad F. Cyclic GMP synthesis and function. Pharmacol. Rev. 39:1987;163-196.
64. Walski M., Owczarska K., Borowicz J. Crystalloid structure in the neuronal nuclei of the cerebral cortex of rats following total ischemia. J. Brain Res. 36:1995;399-410.
65. Wujek J.R., Dority M.D., Frederickson R.C.A., Brunden K.R. Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol. Aging. 17:1996;107-113.
66. Yokota M., Saido T.C., Tani E., Yamamura I., Minami N. Cytotoxic fragment of amyloid precursor protein accumulates in hippocampus after global forebrain ischemia. J. Cereb. Blood Flow Metab. 16:1996;1219-1223.
67. Yoshida T., Waeber C., Huang Z., Moskowitz M.A. Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion. Neurosci. Lett. 194:1995;214-218.
68. Zhang Z.G., Chopp M., Zaloga C., Pollock J.S., Forstermann U. Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke. 24:1993;2016-2022.
69. Zhang F., Iadecola C. Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J. Cereb. Blood Flow Metab. 14:1994;574-580.
70. Zimmermann M. Endothelin in cerebral vasospasm. Clinical and experimental results. J. Neurosurg. Sci. 41:1997;139-151.